Literature DB >> 11854192

Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans.

Kelley L Davis1, Kim S Wise.   

Abstract

The mature MALP-404 surface lipoprotein of Mycoplasma fermentans comprises a membrane-anchored N-terminal lipid-modified region responsible for macrophage activation (P. F. Mühlradt, M. Kiess, H. Meyer, R. Süssmuth, and G. Jung, J. Exp. Med. 185:1951-1958, 1997) and an external hydrophilic region that contains the selective lipoprotein-associated (SLA) motif defining a family of lipoproteins from diverse but selective prokaryotes, including mycoplasmas (M. J. Calcutt, M. F. Kim, A. B. Karpas, P. F. Mühlradt, and K. S. Wise, Infect. Immun. 67:760-771, 1999). This family generally corresponds to a computationally defined group of orthologs containing the basic membrane protein (BMP) domain. Two discrete lipid-modified forms of the abundant MALP product which vary dramatically in ratio among isolates of M. fermentans occur on the mycoplasma surface: (i) MALP-404, the full-length mature product, and (ii) MALP-2, the Toll-like receptor 2-mediated macrophage-activating lipopeptide containing the N-terminal 14 residues of the mature lipoprotein. The role of posttranslational processing in the biogenesis of MALP-2 from the prototype MALP-404 SLA-containing lipoprotein was investigated. Detergent phase fractionation of cell-bound products and N-terminal sequencing of a newly discovered released fragment (RF) demonstrated that MALP-404 was subject to site-specific proteolysis between residues 14 and 15 of the mature lipoprotein, resulting in the cell-bound MALP-2 and soluble RF products. This previously unknown mechanism of posttranslational processing among mycoplasmas suggests that specific cleavage of some surface proteins may confer efficient "secretion" of extracellular products by these organisms, with concurrent changes in the surface phenotype. This newly identified form of variation may have significant implications for host adaptation by mycoplasmas, as well as other pathogens expressing lipoproteins of the SLA (BMP) family.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854192      PMCID: PMC127791          DOI: 10.1128/IAI.70.3.1129-1135.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Interactions between mycoplasma lipoproteins and the host immune system.

Authors:  I Chambaud; H Wróblewski; A Blanchard
Journal:  Trends Microbiol       Date:  1999-12       Impact factor: 17.079

2.  Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.

Authors:  O Takeuchi; A Kaufmann; K Grote; T Kawai; K Hoshino; M Morr; P F Mühlradt; S Akira
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 3.  Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin).

Authors:  J E Alouf
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

4.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing.

Authors:  I Poquet; V Saint; E Seznec; N Simoes; A Bolotin; A Gruss
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

6.  Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.

Authors:  G Piec; J Mirkovitch; S Palacio; P F Mühlradt; R Felix
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2.

Authors:  A Kaufmann; P F Mühlradt; D Gemsa; H Sprenger
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  The complete sequence of the mucosal pathogen Ureaplasma urealyticum.

Authors:  J I Glass; E J Lefkowitz; J S Glass; C R Heiner; E Y Chen; G H Cassell
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

Review 9.  Mycoplasma fermentans interaction with monocytes/macrophages: molecular basis.

Authors:  G Rawadi
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

Review 10.  M161Ag is a potent cytokine inducer with complement activating function (review).

Authors:  M Matsumoto; T Seya
Journal:  Int J Mol Med       Date:  1999-03       Impact factor: 4.101

View more
  16 in total

Review 1.  Interactions between mycoplasma lipid-associated membrane proteins and the host cells.

Authors:  Xiao-xing You; Yan-hua Zeng; Yi-mou Wu
Journal:  J Zhejiang Univ Sci B       Date:  2006-05       Impact factor: 3.066

2.  Homologue of macrophage-activating lipoprotein in Mycoplasma gallisepticum is not essential for growth and pathogenicity in tracheal organ cultures.

Authors:  Philip F Markham; Anna Kanci; György Czifra; Bo Sundquist; Peter Hains; Glenn F Browning
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

3.  Distinctive repertoire of contingency genes conferring mutation- based phase variation and combinatorial expression of surface lipoproteins in Mycoplasma capricolum subsp. capricolum of the Mycoplasma mycoides phylogenetic cluster.

Authors:  Kim S Wise; Mark F Foecking; Kerstin Röske; Young Jin Lee; Young Moo Lee; Anup Madan; Michael J Calcutt
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

4.  Mycoplasma bovis Membrane Protein MilA Is a Multifunctional Lipase with Novel Lipid and Glycosaminoglycan Binding Activity.

Authors:  Glenn Francis Browning; Kelly Anne Tivendale; James Yazah Adamu; Nadeeka Kumari Wawegama; Anna Kanci Condello; Marc Serge Marenda; Philip Francis Markham
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

5.  Mycoplasma hyopneumoniae mhp379 is a Ca2+-dependent, sugar-nonspecific exonuclease exposed on the cell surface.

Authors:  Jonathan A Schmidt; Glenn F Browning; Philip F Markham
Journal:  J Bacteriol       Date:  2007-02-16       Impact factor: 3.490

6.  Proteases as Secreted Exoproteins in Mycoplasmas from Ruminant Lungs and Their Impact on Surface-Exposed Proteins.

Authors:  Sarah Ganter; Guylaine Miotello; Lucía Manso-Silván; Jean Armengaud; Florence Tardy; Patrice Gaurivaud; François Thiaucourt
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

7.  Proteolytic processing of the Mycoplasma hyopneumoniae cilium adhesin.

Authors:  Steven P Djordjevic; Stuart J Cordwell; Michael A Djordjevic; Jody Wilton; F Chris Minion
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Identification and functional mapping of the Mycoplasma fermentans P29 adhesin.

Authors:  Spencer A Leigh; Kim S Wise
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

9.  A Metzincin and TIMP-Like Protein Pair of a Phage Origin Sensitize Listeria monocytogenes to Phage Lysins and Other Cell Wall Targeting Agents.

Authors:  Etai Boichis; Nadejda Sigal; Ilya Borovok; Anat A Herskovits
Journal:  Microorganisms       Date:  2021-06-18

10.  P80, the HinT interacting membrane protein, is a secreted antigen of Mycoplasma hominis.

Authors:  Miriam Hopfe; Ricarda Hoffmann; Birgit Henrich
Journal:  BMC Microbiol       Date:  2004-12-06       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.